Y Intercept Hong Kong sold 70.4% of its Regeneron shares in Q3 amid strong earnings and revenue.

Y Intercept Hong Kong Ltd reduced its stake in Regeneron Pharmaceuticals by 70.4% in the third quarter, selling 24,556 shares, while the company posted strong earnings of $11.83 per share, surpassing estimates, and reported $3.75 billion in revenue. The stock, trading at $753.55, has a market cap of $79.2 billion and a consensus "Moderate Buy" rating with a target of $794.70. Insider sales totaled $5.7 million over 90 days, and Regeneron paid a $0.88 quarterly dividend.